Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific Group Inc. Processing Laboratory Nearing Completion.


SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:BMSN BMSN Seaman, Boatswain's Mate Striker (Naval Rating) ), a biotechnology company focused on stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 cryogenics cryogenics: see low-temperature physics.
cryogenics

Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties.
 and disposable stem cell / tissue transfer instruments, announced today that the new Class 10,000 Processing Laboratory is now 95% completed, with 100% completion scheduled by mid-October. Validation of the new Class 10,000 Processing Laboratory is scheduled to begin on October 16th.

Clean Rooms West, the main contractor of record, was selected by Bio-Matrix Scientific Group, Inc. as the prime contractor to design, develop, build and install the new class 10,000 processing laboratory.

Brian Pockett, Managing Director and COO, stated, "We are very excited to see the professional work of Cleans Rooms West and the ongoing transformation of our facility."

Bio-Matrix' new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego, will house:

* Bio-Matrix' secure Cryogenic Stem Cell Bank,

* 3 Research laboratories,

* An aseptic aseptic /asep·tic/ (-tik) free from infection or septic material.

a·sep·tic
adj.
Of, relating to, or characterized by asepsis.
 cellular/tissue class 10,000/100 processing laboratory,

* Hematology, microbiology and flow cytometry flow cytometry (flōˑ sī·tˑ·m  laboratories.

This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. Visit the Company's website at www.BMXGonline.com for more information.

The Company aligns itself with strategic partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.

DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 10, 2006
Words:403
Previous Article:TippingPoint's Zero Day Initiative Uncovers Three Microsoft Vulnerabilities and Protects Customers from Zero Day Attacks.
Next Article:Fairchild Semiconductor Says Lawsuit is Not Over and it Expects to Ultimately Prevail Against Power Integrations.
Topics:



Related Articles
Bio-Matrix Announces Contract with Emergo Group Inc. for FDA cGMP/cGTP Compliance and ISO 13485:2003 Certification.
Bio-Matrix Files US and International Utility Patents on Its Stem Cell Extraction Medical Devices.
Bio-Matrix Announces the Completion of Its Medical Device Engineering, Testing and Research Laboratory.
Tasco Holdings International Announces It is Beginning Search for Stem Cell Laboratory Director.
Bio-Matrix Scientific Group Inc. Announces New Website Address.
Bio-Matrix Scientific Group Inc. Starts Final Phase of Class 10,000 Processing Laboratory Installation.
Bio-Matrix Scientific Group Inc. Update on Class 10,000 Stem Cell Banking and Cellular Tissue Processing Laboratories.
Bio-Matrix Announces Construction and Installation of the Class 10,000 Stem Cell Cellular Tissue Processing Laboratory Completed.
Bio-Matrix Scientific Receives Certificate of Compliance for Class 10,000 Processing Laboratory.
Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived from Fat and Medical Devices Aimed at Plastic Surgeons...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles